bioRxiv Science⌕ Search

Biology subjects

Bacic, L.

Publications and source records attributed to Bacic, L..

2 recordsLinked to original sources

ALC1 Finds a New Foothold on the Nucleosome's Super-Groove

Nucleosomes act as recognition platforms for chromatin-binding factors that coordinate genome maintenance. A distinct structural feature of the nucleosome is the alignment of the DNA major and minor grooves across both gyres, forming continuous major and minor super-grooves. Despite this prominent feature, only one example of a naturally occurring protein binding to a super-groove is documented at the structural level to date. The chromatin remodeler Amplified in Liver Cancer 1 (ALC1) is a key component of the DNA damage response and a promising therapeutic target in cancer. Through extensive classification of our cryo-electron microscopy data, we identified a previously unresolved ALC1-nucleosome complex characterized by a loosely bound conformation of ALC1. This conformation represents an intermediate between the auto-inhibited and active states, and provides new structural insights into the conformational transitions that regulate ALC1 activity. In this intermediate state, the linker of ALC1 engages the nucleosomes minor DNA super-groove across both gyres in a recognition mode observed for the first time in a naturally occurring protein. SynopsisRe-analysis of a publicly available cryo-EM dataset identifies an intermediate state of the oncogenic chromatin remodeler ALC1, revealing the conformational change leading to its activation upon binding to a PARylated nucleosome. The remodeler recognizes the nucleosomes super-groove.

biophysics↗

Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome

The chromatin remodeler ALC1 is recruited to and activated by DNA damage-induced poly(ADP-ribose) (PAR) chains deposited by PARP1/PARP2/HPF1 upon detection of DNA lesions. ALC1 has emerged as a candidate drug target for cancer therapy as its loss confers synthetic lethality in homologous recombination-deficient cells. However, structure-based drug design and molecular analysis of ALC1 have been hindered by the requirement for PARylation and the highly heterogeneous nature of this post-translational modification. Here, we reconstituted an ALC1 and PARylated nucleosome complex modified in vitro using PARP2 and HPF1. This complex was amenable to cryo-EM structure determination without cross-linking, which enabled visualization of several intermediate states of ALC1 from the recognition of the PARylated nucleosome to the tight binding and activation of the remodeler. Functional biochemical assays with PARylated nucleosomes highlight the importance of nucleosomal epitopes for productive remodeling and reveal that ALC1 preferentially slides nucleosomes away from DNA breaks.

biophysics↗